Search companies or stocks...
CRISPR Therapeutics AG (CRSP) intrinsic value snapshot: our valuation models currently suggest the stock is undervalued, with an estimated 49.0% upside relative to fair value at a market price of $60.90. Unlock the dollar fair value estimate for CRISPR Therapeutics AG with Tickerplace Pro.
Current Price: $60.90
Valuation: Undervalued
Confidence: 8.0/10
How we calculate fair value: We combine DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models to estimate intrinsic value. This figure is for information only - not investment advice - and assumptions may not reflect actual market conditions. We encourage doing your own research or speaking with a financial advisor before making investment decisions.
Search our company database (same as the site header), pick a match, or type a ticker to open its intrinsic value analysis.
The verdict and fair-value gap for CRISPR Therapeutics AG (CRSP) are summarised in the intrinsic value snapshot above. This section explains the method: we compare the live market price with modeled fair value using DCF, P/E Multiple, and P/S Multiple approaches. Assumptions can change with new earnings, growth, and discount-rate inputs, so treat the result as a research aid rather than a buy or sell signal. Tickerplace Pro unlocks the dollar fair value used in that comparison.
Use this section for context around the gap, not a third restatement of the top-line verdict. The free snapshot above already shows the percentage gap and market price; the dollar intrinsic value stays behind Tickerplace Pro. Compare CRSP with related intrinsic-value pages listed below (KRYS, MTSR, S, and more) to see how peers are framed on the same models.
Our models calculate the intrinsic value of CRISPR Therapeutics AG (CRSP) using DCF, P/E Multiple, and P/S Multiple approaches based on projected cash flows, growth rate, and discount rate. Sign in to Tickerplace Pro to view the full dollar estimate.
Based on our 2026 valuation models, CRSP appears undervalued at its current price of $60.90. Our model suggests 49.0% upside potential.
Tickerplace calculates CRSP's intrinsic value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We project future cash flows, apply a discount rate that reflects investment risk, and compare the resulting fair value estimate to the current market price.
Peers for CRSP: open their intrinsic value pages.
